Financials in GBp. Standardized financial statements.
A compact view of how Creo Medical Limited turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | £6.00M | £4.00M | £30.80M | £27.17M | £25.16M | £9.43M | £13,473 | £0 | £0 | £0 |
| Revenue Growth? | +50.0% | -87.0% | +13.4% | +8.0% | +166.8% | +69884.4% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | £4.60M | £2.10M | £15.50M | £17.16M | £16.14M | £6.99M | £650,246 | £331,610 | £0 | £142,423 |
| Gross Profit? | £1.40M | £1.90M | £15.30M | £10.01M | £9.02M | £2.44M | -£636,773 | -£331,610 | £0 | -£142,423 |
| Gross Margin? | +23.3% | +47.5% | +49.7% | +36.8% | +35.9% | +25.9% | -4726.3% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | £22.10M | £30.70M | £40.10M | £40.82M | £38.98M | £25.83M | £18.38M | £11.61M | £10.29M | £8.90M |
| Operating Income? | -£20.70M | -£28.80M | -£24.80M | -£30.81M | -£29.96M | -£23.39M | -£19.02M | -£11.94M | -£10.29M | -£8.90M |
| EBITDA? | -£19.70M | -£26.10M | -£20.70M | -£27.62M | -£27.54M | -£21.77M | -£17.96M | -£11.37M | -£9.97M | -£8.76M |
| Income Before Tax | -£17.50M | -£29.00M | -£24.50M | -£30.98M | -£30.34M | -£23.46M | -£18.62M | -£11.72M | -£10.29M | -£8.91M |
| Income Tax Expense | £0 | -£1.20M | -£2.80M | -£4.04M | -£5.74M | -£3.15M | -£2.70M | -£1.85M | -£1.88M | -£1.14M |
| Net Income? | £5.30M | -£28.70M | -£21.70M | -£26.94M | -£24.59M | -£20.32M | -£15.91M | -£9.87M | -£8.41M | -£7.77M |
| EPS? | £0.01 | £-0.08 | £-0.07 | £-0.14 | £-0.14 | £-0.13 | £-0.13 | £-0.11 | £-0.10 | £-0.13 |
| Diluted EPS? | £0.01 | £-0.08 | £-0.07 | £-0.14 | £-0.14 | £-0.13 | £-0.13 | £-0.11 | £-0.10 | £-0.12 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality